The Airvo Device and Oxygen Administration in Exacerbation of Chronic Obstructive Pulmonary Disease

Not Applicable

Completed

• Conditions: Chronic obstructive pulmonary disease; Respiratory - Chronic obstructive pulmonary disease

• Registration Number: ACTRN12613000447752
• Lead Sponsor: Medical Research Institute of New Zealand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-04-18
• Study Completion: 2014-12-31
• Last Update Posted: 14 June 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Twenty four participants with COPD will be recruited from Wellington Regional Hospital during an acute exacerbation. To be eligible participants will be receiving oxygen via standard nasal prongs, without any non invasive assisted ventilation at recruitment.

Exclusion Criteria

1.Age under 16 years
2.Any other condition which, at the investigator’s discretion, is believed may present a safety risk or impact the feasibility of the study or the study results.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Transcutaneous carbon dioxide (PtCO2), adjusted for baseline, measured via a TOSCA. [30 minutes.]

Secondary Outcome Measures

Name	Time	Method
Transcutaneous carbon dioxide, adjusted for baseline, measured via a TOSCA with continuous recording. [Continuous recording. Individual time points of every 5 minutes during intervention and washout/observation period];Respiratory rate, adjusted for baseline, measured via observation of patient and counting at 5 minute time points. [Every 5 minutes during intervention and washout/observation period. ];Mean oxygen saturations, adjusted for baseline, measured via a TOSCA with continuous recording.[Continuous recording. Individual time points of every 5 minutes during intervention and washout/observation period. ];Heart Rate, adjusted for baseline, measured via a TOSCA with continuous measuring. [Continuous recording. Individual time points of every 5 minutes during intervention and washout/observation period. ];Comfort of the Airvo or nasal prongs by a questionnaire using 5 point scales and open ended questions.[Asked at end of trial session.]